Delivery Order 36E79722D0009-15B30326F00000036
- Not listed
- Seqirus USA Inc., a Summit, New Jersey-based biotechnology company specializing in influenza vaccine manufacturing and distribution, has been awarded a delivery order by the Federal Correctional Complex Terre Haute (operating under the Department of Justice Bureau of Prisons) for FY26 B1 inmate flu vaccines. This firm fixed-price delivery order, valued at $1,633.24, carries an ultimate completion date of October 15, 2026, and represents procurement from a larger vehicle supporting the federal...
- Seqirus USA Inc. has been awarded a delivery order by the Federal Correctional Institution Big Spring, a civilian facility under the Department of Justice, to supply influenza vaccines for the 2026-2027 season. The contract is a firm fixed-price delivery order with a ceiling value of $6,999.60 and an ultimate completion date of April 30, 2026. The vaccine will be delivered to the contractor's headquarters location in Summit, New Jersey. This award carries no set-aside designation, reflecting the...
- Seqirus USA Inc. has been awarded a delivery order valued at $4,199.76 by the Medical Center for Federal Prisoners Springfield to supply influenza vaccines for inmate vaccination in September 2026. This firm fixed-price delivery order, with an ultimate completion date of September 30, 2026, represents a continuation of Seqirus's established role as a primary vaccine supplier to the Bureau of Prisons. The award is issued without a set-aside designation and reflects the company's competitive...
- Seqirus USA Inc. was awarded a delivery order valued at $5,097.57 by the Federal Correctional Institution Edgefield, a civilian agency under the Department of Justice Bureau of Prisons, for the procurement of influenza vaccines for staff. The award, issued on April 1, 2025, with an ultimate completion date of October 15, 2025, is structured as a firm fixed-price delivery order with no set-aside designation. Performance will be completed at the vendor's facility in Summit, New Jersey. This...
- Seqirus USA Inc., a biotechnology company headquartered in Summit, New Jersey, was awarded a delivery order by the Federal Prison Camp Alderson (a civilian facility under the Bureau of Prisons) for inmate flu vaccine services in the second quarter of fiscal year 2026. The contract, valued at $2,541.60, is a firm fixed-price delivery order with no set-aside designation, with an ultimate completion date of September 30, 2026. Performance will take place in Alderson, West Virginia. This delivery...
- Seqirus USA Inc. was awarded a firm fixed-price delivery order valued at $1,762.92 to supply influenza virus vaccine for the 2025-2026 season to the inmate population at Federal Correctional Institution Jesup, Georgia. The contract, issued on April 1, 2025, with an ultimate completion date of October 31, 2025, is being funded by the Bureau of Prisons under the Department of Justice. This delivery order is issued under Contract No. 36E79725D0006 and does not utilize a set-aside designation,...
- Seqirus USA Inc. was awarded a firm fixed price delivery order by the Department of Justice Bureau of Prisons Federal Correctional Institution Greenville to supply inmate influenza vaccines. The $7,610.06 contract has a completion date of February 20, 2024 and was awarded on March 30, 2021 without a set-aside designation. As the prime contractor, Seqirus USA Inc. will deliver influenza virus vaccines to support immunization programs for federal inmates and correctional facility staff at the...
- Seqirus USA Inc. has been awarded a delivery order contract valued at $1,551 by the Federal Correctional Institution Manchester, a civilian agency under the Department of Justice Bureau of Prisons, for the supply of influenza vaccines. The contract, which is firm fixed price with no set-aside designation, has an ultimate completion date of January 7, 2026, and will be performed in Summit, New Jersey, where Seqirus maintains its primary operations. This delivery order represents a continuation of...
- This is a firm-fixed-price delivery order contract awarded by the Federal Correctional Complex Butner, part of the U.S. Department of Justice, to Seqirus USA Inc. for the supply of influenza virus vaccines for inmates during the 2025-2026 season. The contract has a ceiling value of $17,836.50 and a completion date of September 30, 2025. Seqirus USA Inc., a foreign-owned, for-profit manufacturer of pharmaceutical goods, will provide a range of influenza vaccine formulations to support the...
- This delivery order, awarded on March 17, 2026, to Seqirus USA Inc. for $2,333.20, provides influenza vaccines to the Administrative Security US Penitentiary Thomson facility operated by the Federal Bureau of Prisons. The contract is a firm fixed-price delivery order with no set-aside designation, with a completion date of April 15, 2026. Seqirus USA Inc., headquartered in Summit, New Jersey, is a leading federal supplier of seasonal influenza vaccination products and has been a registered...
- 36E79722D0009Indefinite Delivery Contract
- 36E79722D0009-15B30326F00000036Delivery Order
Seqirus USA Inc., a New Jersey-based biotechnology company specializing in influenza vaccine development and manufacturing, received a delivery order award from the Federal Correctional Institution Edgefield on October 1, 2026, valued at $2,859.30. This firm fixed-price delivery order, with no set-aside designation, covers flu vaccine procurement for inmates age 65 and older and staff at the correctional facility. The contract will be performed in Swiftwater, Pennsylvania, with a completion date of September 30, 2027. This award falls under the Department of Justice Bureau of Prisons, which has established Seqirus as a critical supplier of seasonal influenza vaccination products across multiple correctional institutions nationwide. This delivery order represents a continuation of Seqirus's substantial federal vaccine supply relationships. The company maintains multiple indefinite delivery contracts with major federal health agencies, including a $30.9 million contract with the VA National Acquisition Center for the 2026-2027 flu season and significant CDC multiple-award contracts totaling hundreds of millions in ceiling value for both adult and pediatric influenza vaccines. As a registered federal contractor since 2008, Seqirus has demonstrated consistent capacity to support diverse federal immunization requirements across correctional facilities, veterans' healthcare systems, tribal health programs, and military supply chains.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.9k | 4/13/26 |